Guerbet Group Overview

  • Founded
  • 1926

Founded
  • Status
  • Public

  • Employees
  • 2,290

Employees
  • Stock Symbol
  • GBT

Stock Symbol
  • Investments
  • 5

  • Share Price
  • $17.33

  • (As of Monday Closing)

Guerbet Group General Information

Description

Guerbet SA is a healthcare company that manufactures and markets medical imaging contrast agents destined for diagnostic purposes. Its products include medical imaging contrast products for x-ray imaging, magnetic resonance imaging, ultrasound imaging and for nuclear medicine. The company markets its products under the brand names such as Xenetix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol.

Contact Information

Website
www.guerbet.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Diagnostic Equipment
Stock Exchange
PAR
Primary Office
  • 15 Rue Des Vanesses
  • Zone Paris Nord II
  • 93420 Villepinte
  • France
+33 01 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Guerbet Group Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$17.33 $17.69 $14.97 - $43.72 $223M 12.6M 18K $1.11

Guerbet Group Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 490,442 766,504 753,900 912,749
Revenue 837,700 870,067 816,941 916,829
EBITDA 84,669 106,645 98,791 130,680
Net Income 14,174 38,587 20,792 41,787
Total Assets 1,050,393 1,133,164 1,163,188 1,130,105
Total Debt 324,046 376,511 433,046 423,321
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Guerbet Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Guerbet Group‘s full profile, request access.

Request a free trial

Guerbet Group Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Guerbet SA is a healthcare company that manufactures and markets medical imaging contrast agents destined for diagnostic
Diagnostic Equipment
Villepinte, France
2,290 As of 2022
00000000

000000

is aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
00000 0000000 000 00000000
North Billerica, MA
000 As of 0000
00000
000000000 00 00000

000000

ing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
0000000000 000000000
Montclair, NJ
0 As of 0000
0000
000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Guerbet Group Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lantheus Medical Imaging Formerly PE-Backed North Billerica, MA 000 00000 000000000 00 00000
000000000000 Formerly VC-backed Montclair, NJ 0 0000 000000000 0000
000000000 Formerly VC-backed Burlington, MA 000 00000 000000&0 00000
000000 0000000000 Formerly PE-Backed Stockholm, Sweden 00 000.00 000000&0 000.00
00000000 Private Equity-Backed Peabody, MA 0000 000.00 000000000 000.00
You’re viewing 5 of 8 competitors. Get the full list »

Guerbet Group Patents

Guerbet Group Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4016106-A1 Methods for training at least a prediction model for medical imaging, or for processing at least a pre-contrast image depicting a body part prior to an injection of contrast agent using said prediction model Pending 18-Dec-2020 00000000000 0
EP-4016107-A1 Methods for training a cnn and for processing an inputted perfusion sequence using said cnn Pending 18-Dec-2020 000000000000 0
EP-3978046-A1 Medical injection device with gas evacuation Pending 30-Sep-2020 00000000000 0
EP-3944850-A1 Multi-part adapter assembly for bulk medical fluid container Pending 31-Jul-2020 000000000
EP-4041318-A1 Non-degradable embolisation microsphere Pending 07-Oct-2019 A61L24/0015
To view Guerbet Group’s complete patent history, request access »

Guerbet Group Executive Team (10)

Name Title Board Seat Contact Info
David Hale Chief Executive Officer
Jérôme Estampes Group Chief Financial Officer & Senior Vice President, Business Development & Licensing
Marcello Bellato Chief Information Officer
Anita Shrader Interventional Imaging Director, Sales and Marketing
Gitte Hesselholt Chief Commercial Officer, Americas & EMEA
You’re viewing 5 of 10 executive team members. Get the full list »

Guerbet Group Board Members (4)

Name Representing Role Since
000000 00000000 Guerbet Group Board Member 000 0000
000000 000000 Self Board Member 000 0000
000000 0000000-000 Guerbet Group Board Member 000 0000
00000000 000000 Guerbet Group Board Member 000 0000
To view Guerbet Group’s complete board members history, request access »

Guerbet Group Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Guerbet Group Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 02-Aug-2018 0000000000 000.00 Surgical Devices 0000 0'00
00000000 (000 26-Apr-2018 000000000 00.000 Buildings and Property
000000000000 27-Nov-2015 0000000000 00000 Diagnostic Equipment 0000 0'00
00000 0000000 01-Jan-2010 000000000 Drug Delivery
Medex Biomedical 01-Jun-2004 Merger/Acquisition 00.000 Drug Delivery
To view Guerbet Group’s complete investments and acquisitions history, request access »